Anthem, Inc. (ANTM) is scheduled to report second-quarter/15 results before the markets open today. Wall Street analysts are on average expecting the health benefits operator to post $19.64 billion in sales during the quarter. This would show an increase of 4.57% from the Q4/14 revenue of $18.78 billion. EPS are expected to come in at $2.75, a decline rate of 14.18% from $3.14 per share from Q1/15. Meanwhile, EarningsWhisper.com reports a whisper number of $2.75 per share.
On valuation measures, Anthem, Inc., currently valued at $40.79 billion, has a median Wall Street price target of $180.00 with a high target of $222.00.
In the past 52 weeks, shares of Indianapolis, Indiana-based $40.79B market cap company have traded between a low of $106.52 and a high of $173.59 with the 50-day MA and 200-day MA located at $161.40 and $153.21 levels, respectively. Additionally, shares of ANTM trade at a P/E ratio of 1.35 and have a Relative Strength Index (RSI) and MACD indicator of 39.08 and -4.22, respectively.
ANTM currently prints a one year return of about 36% and a year-to-date return of around 24%.